Servier and Day One Biopharmaceuticals Inc. jointly announced an acquisition agreement, which will significantly enhance Servier's product pipeline in the field of rare tumor treatments.

老虎证券2026/03/06 13:54

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Through this strategic acquisition, Servier aims to accelerate the research and commercialization of its rare oncology drugs, providing more advanced treatment options for patients worldwide.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Servier and Day One Biopharmaceuticals Inc. jointly announced an acquisition agreement, which will significantly enhance Servier's product pipeline in the field of rare tumor treatments.

You may also like

Crypto prices